• Affiliate Associate Professor, Global Health
Photo of Ajoke Sobanjo-ter Meulen

Box 357965
Seattle, WA
United States

Phone Number: 
Select from the following:

Ajoke Sobanjo-ter Meulen is a Senior Program Officer with the Bill and Melinda Gates Foundation. She leads the foundation’s maternal immunization initiative. Most recently, Ajoke was Cluster Head at Novartis, Cambridge, where she managed the Phase 2 maternal immunization clinical development program for the Group B streptococcus vaccine. Previously, Ajoke served as Associate Director Vaccine Clinical Research at Merck Research Laboratories she was a clinical development leader in Discovery through phase 3. Before joining industry, she coordinated the Child Health and Neglected Diseases program at the German bilateral agency (GIZ), as well as a large multi-center trial on HIV drug resistance monitoring and surveillance in Africa and Asia for the Netherlands Aids Foundation. Ajoke completed her residency in pediatric and adolescent medicine at the University of Wuerzburg, Germany, and did her pediatric infectious disease fellowship at Mount Sinai Medical School, New York. She holds a M.D. degree from the University of Berlin, a Dr. med. degree from the Institute of Tropical Medicine Hamburg; and a M.Sc. degree in Epidemiology from the London School of Hygiene and Tropical Medicine.

  • MD (Free University of Berlin)
  • MSc (London School of Hygiene & Tropical Medicine (UK))
Country Affiliations 
  • French
  • German
Health Topics 
  • Disease Surveillance
  • Drug and Vaccine Development
  • Infectious Diseases
  • Maternal Child Health (incl. Reproductive Health)

Engmann, C, Fleming JA, Khan S, Innis B, Smith J, Hombach J, Sobanjo-ter Meulen A. 2020. Closer and closer? Maternal Immunization: Current promise, future horizons. J Perinat Jun;40(6):844-857, 2020

Sobanjo-ter Meulen A, Liljestrand J, Hombach J et al. Preparing to introduce new maternal immunizations in low- and lower-middle-income countries: A report from the Bill & Melinda Gates Foundation convening “Allies in Maternal and Newborn Care”; May 3-4, 2018. 2020. Vaccine 38 (28) June 2020, p 4355-4361

Sobanjo-ter Meulen A, Munoz FM, Kaslow DC, Klugman KP, Omer SB, Vora A, Stergachis A. 2019. Maternal interventions vigilance harmonization in low- and middle-income countries: Stakeholder meeting report: Amsterdam, May 1-2, 2018. Vaccine 2019, May 6:37(20):2643-2650

Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Blencowe H, Cousens S, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag SJ, Sobanjo-ter Meulen A, Vekemans J, Lawn JE. 2017. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis 2017, Nov 6;65:S200-S219